Genfit S.A. Return on Equity

Genfit S.A. (GNFTF) currently reports a ROE of 284.57%. That is above the Healthcare sector average of -75.59%. Use the charts on this page to explore Genfit S.A.'s ROE history and peer comparisons.

Genfit S.A.'s ROE of 284.57% is higher than the Healthcare sector average of -75.59%. That is roughly 476.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Genfit S.A.'s current 284.57% should be judged against Healthcare norms (sector average: -75.59%) and against GNFTF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 284.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.59%. From there, open related valuation or income-statement pages for Genfit S.A., and consider following GNFTF for alerts when major investors trade the stock.

Genfit S.A. is classified in the Healthcare sector. On ROE, it currently shows 284.57% versus a sector average near -75.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GNFTF with unrelated industries.